249 related articles for article (PubMed ID: 17360142)
1. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease.
Feringa HH; Karagiannis SE; van Waning VH; Boersma E; Schouten O; Bax JJ; Poldermans D
J Vasc Surg; 2007 May; 45(5):936-43. PubMed ID: 17360142
[TBL] [Abstract][Full Text] [Related]
2. Lower progression rate of end-stage renal disease in patients with peripheral arterial disease using statins or Angiotensin-converting enzyme inhibitors.
Feringa HH; Karagiannis SE; Chonchol M; Vidakovic R; Noordzij PG; Elhendy A; van Domburg RT; Welten G; Schouten O; Bax JJ; Berl T; Poldermans D
J Am Soc Nephrol; 2007 Jun; 18(6):1872-9. PubMed ID: 17475817
[TBL] [Abstract][Full Text] [Related]
3. Effect of statin therapy on mortality in patients with peripheral arterial disease and comparison of those with versus without associated chronic obstructive pulmonary disease.
van Gestel YR; Hoeks SE; Sin DD; Simsek C; Welten GM; Schouten O; Stam H; Mertens FW; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Jul; 102(2):192-6. PubMed ID: 18602520
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease.
Thatipelli MR; Pellikka PA; McBane RD; Rooke TW; Rosales GA; Hodge D; Herges RM; Wysokinski WE
J Vasc Surg; 2007 Jul; 46(1):62-70; discussion 70. PubMed ID: 17583463
[TBL] [Abstract][Full Text] [Related]
5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
6. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery.
Feringa HH; Schouten O; Karagiannis SE; Brugts J; Elhendy A; Boersma E; Vidakovic R; van Sambeek MR; Noordzij PG; Bax JJ; Poldermans D
J Am Coll Cardiol; 2007 Oct; 50(17):1649-56. PubMed ID: 17950146
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.
Feringa HH; van Waning VH; Bax JJ; Elhendy A; Boersma E; Schouten O; Galal W; Vidakovic RV; Tangelder MJ; Poldermans D
J Am Coll Cardiol; 2006 Mar; 47(6):1182-7. PubMed ID: 16545650
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of declining ankle-brachial index values in patients with suspected or known peripheral arterial disease.
Feringa HH; Karagiannis SE; Schouten O; Vidakovic R; van Waning VH; Boersma E; Welten G; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):206-13. PubMed ID: 17481930
[TBL] [Abstract][Full Text] [Related]
9. Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.
Gitt AK; Juenger C; Jannowitz C; Karmann B; Senges J; Bestehorn K
Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):438-44. PubMed ID: 19369876
[TBL] [Abstract][Full Text] [Related]
10. Statin use in patients with extremely low low-density lipoprotein levels is associated with improved survival.
Leeper NJ; Ardehali R; deGoma EM; Heidenreich PA
Circulation; 2007 Aug; 116(6):613-8. PubMed ID: 17664373
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
Tani S; Nagao K; Hirayama A
Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
[TBL] [Abstract][Full Text] [Related]
12. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
13. Baseline low-density lipoprotein cholesterol levels and outcome in patients with heart failure.
Charach G; George J; Roth A; Rogowski O; Wexler D; Sheps D; Grosskopf I; Weintraub M; Keren G; Rubinstein A
Am J Cardiol; 2010 Jan; 105(1):100-4. PubMed ID: 20102899
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
15. Low high-density lipoprotein cholesterol is not a risk factor for recurrent vascular events in patients with vascular disease on intensive lipid-lowering medication.
van de Woestijne AP; van der Graaf Y; Liem AH; Cramer MJ; Westerink J; Visseren FL;
J Am Coll Cardiol; 2013 Nov; 62(20):1834-41. PubMed ID: 23948286
[TBL] [Abstract][Full Text] [Related]
16. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
Spencer FA; Goldberg RJ; Gore JM; Fox KA; Avezum A; Agnelli G; Kritharides L; Anderson FA; Goodman SG; FitzGerald G; Allegrone J; Brieger D;
Am J Cardiol; 2007 Sep; 100(6):913-8. PubMed ID: 17826369
[TBL] [Abstract][Full Text] [Related]
17. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
18. The association of lipid-modifying medications with mortality in patients on long-term peritoneal dialysis.
Goldfarb-Rumyantzev AS; Habib AN; Baird BC; Barenbaum LL; Cheung AK
Am J Kidney Dis; 2007 Nov; 50(5):791-802. PubMed ID: 17954292
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of hypotensive blood pressure response during single-stage exercise test on long-term outcome in patients with known or suspected peripheral arterial disease.
de Liefde II; Hoeks SE; van Gestel YR; Klein J; Verhagen HJ; van Domburg RT; Poldermans D
Coron Artery Dis; 2008 Dec; 19(8):603-7. PubMed ID: 19005295
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of hypertensive blood pressure response during a single-stage exercise test to predict long-term outcome in patients with peripheral arterial disease.
de Liefde II; Hoeks SE; van Gestel YR; Bax JJ; Klein J; van Domburg RT; Poldermans D
Am J Cardiol; 2008 Oct; 102(7):921-6. PubMed ID: 18805123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
